Mark Barrett
Chief Business Officer Madrigal Pharmaceuticals
Mark Barrett brings more than 25 years of executive leadership and biopharmaceutical industry experience to Madrigal, with a track record of success completing a wide range of partnerships and acquisitions to build commercial portfolios and R&D pipelines across therapeutic areas. Most recently, he was CEO, Co-founder, and Director of Lassen Therapeutics, a biotechnology company focused on development of novel antibody therapeutics in immunological diseases and cancer. Mr. Barrett also served as Entrepreneur in Residence at Frazier Healthcare Partners, where he focused on starting and financing new biotech companies. Prior to Lassen, he held leadership positions in Strategy and Business Development at Johnson & Johnson and Sanofi.
Seminars
- Understand what investors and pharmaceutical partners look for
- Learn how to find and build relationships with investors/partners interested in your field
- Gain insights into the key conferences, partnering forums and networking platforms that are shaping investment and dealmaking
